Product Information
NATEGLINIDE 120 MG TABLET is a generic product labeled by Modavar Pharmaceuticals LLC, priced at $0.2222 per EA under NDC 72241000305. Its NADAC has been published 54 times since Sep 24, 2025.
FDA first approved this application on Apr 19, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
120 mg/1
Manufacturer
Modavar Pharmaceuticals LLCNDC
72241000305
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NATEGLINIDEApproval Type
Generic (ANDA)
FDA Application
ANDA206432FDA Approved
4/19/2019
TE Code
AB
On Market Since
8/19/2021
Pharmacological Classes
Price Statistics
The NADAC for NATEGLINIDE 120 MG TABLET has been published 54 times since Sep 24, 2025, and over the history we have for it it has declined 8.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2222 per EA |
|---|---|
| All-time high | $0.2609 (Jan 14, 2026) |
| All-time low | $0.2222 (Sep 23, 2026) |
| 52-week high | $0.2609 |
| 52-week low | $0.2222 |
| Median price | $0.2495 |
| Average price | $0.2475 |
| Largest weekly change | -5.2% (Sep 23, 2026) |
| Weeks tracked | 54 |
| Tracking since | Sep 24, 2025 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Modavar Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Nateglinide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Glinide class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NATEGLINIDE 120 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NATEGLINIDE 120 MG TABLET, manufactured by Modavar Pharmaceuticals LLC, is $0.2222 per EA (NDC 72241000305), effective Sep 30, 2026.
How has the price of NATEGLINIDE 120 MG TABLET changed over time?
Over the history we have for it, the NADAC for NATEGLINIDE 120 MG TABLET has declined 8.8%. It has been tracked across 54 weekly CMS publications since Sep 24, 2025.
What are the highest and lowest recorded NADAC prices for NATEGLINIDE 120 MG TABLET?
Since Sep 24, 2025, the NADAC for NATEGLINIDE 120 MG TABLET has ranged from a low of $0.2222 (Sep 23, 2026) to a high of $0.2609 (Jan 14, 2026), with a median of $0.2495 per EA.
Are there cheaper alternatives to NATEGLINIDE 120 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as NATEGLINIDE 120 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures NATEGLINIDE 120 MG TABLET?
NATEGLINIDE 120 MG TABLET (NDC 72241000305) is labeled by Modavar Pharmaceuticals LLC, and CMS classifies it as a generic product.